Telemedicine in Inflammatory Bowel Disease

Journal article


Authors/Editors


Research Areas

No matching items found.


Publication Details

Subtitle: Opportunities and Approaches
Author list: Peris MA, Del Hoyo J, Bebia P, Faubel R, Barrios A, Bastida G, Valdivieso B, Nos P
Publisher: Wiley: No OnlineOpen / Oxford University Press (OUP): Policy B - Oxford Open Option B - CC-BY
Publication year: 2015
Volume number: 21
Issue number: 2
Start page: 392
End page: 399
Number of pages: 8
ISSN: 1078-0998
Languages: English-Great Britain (EN-GB)


Abstract

This review article summarizes the evidence about telemedicine applications (e.g., telemonitoring, teleconsulting, and tele-education) in the management of patients with inflammatory bowel disease (IBD), and we aim to give an overview of the acceptance and impact of these interventions on health outcomes. Based on the literature search on inflammatory bowel disease, Crohn's disease and ulcerative colitis in combination with e-health, telemedicine, and telemanagement, we selected 58 titles and abstracts published up to June 2014 and searched in PubMed, EMBASE, MEDLINE, Cochrane Database, Web of Science and Conference Proceedings. Titles and abstracts were screened for a set of inclusion criteria: e-health intervention, IBD as the main disease, and a primary study performed. Finally, 16 were included for full reading, data extraction, and critical appraisal of the evaluation. Most studies use telemonitoring (home telemanagement system or web portal) and telecare (real-time telephone and image) as telemedicine applications and assessed the feasibility and acceptance of these systems, adherence to treatment, quality of life, and patient knowledge, particularly in patients with ulcerative colitis. Furthermore, some of these studies evaluated the patients' empowerment, health care costs, and safety of telemonitoring in IBD. In conclusion, the health outcomes of telemedicine applications in IBD suggest that these could be implemented in clinical practice because they are safe and feasible applications that are well accepted by the patient and improve adherence, quality of life, and disease knowledge. Further studies with large sample sizes and complex diseases are needed to confirm these results.


Keywords

No matching items found.


Documents

No matching items found.

Last updated on 2019-23-08 at 11:15